ETNPPL

mutation — cross-omics
Cross-omicsMUTATION → DRUGCell-linePairwise association · TCGA cohorts

Across TCGA cell cohorts, ETNPPL mutation is significantly associated with the drug of many other genes, with 8 significant associations in total. LARGE_INTESTINE shows the largest number of these associations.

The most reproducible ETNPPL-associated genes across cancer lineages are GSK2801, Dihydrorotenone, and OF-1. Each is linked with ETNPPL in more than 1 cancer types. Because this analysis shows association rather than direction, both ETNPPL-to-partner and partner-to-ETNPPL results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, GSK2801 grouped by ETNPPL-low versus ETNPPL-high in LARGE_INTESTINE.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ETNPPL→partner) and Y-score (partner→ETNPPL) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LARGE_INTESTINEGSK2801 →+0.329+2.649.038.04631
LARGE_INTESTINEDihydrorotenone →+0.498+2.649.014.04631
LARGE_INTESTINEOF-1 →+0.285+2.868.038.02221
LARGE_INTESTINEPD0325901 →-0.754-2.745.002.04711
LARGE_INTESTINESCH772984 →-0.698-2.745.006.04711
LARGE_INTESTINEAZD5991 →+0.873+2.649.022.04611
Each partner links to its Q-omics profile. Showing the 6 strongest of 8 associations by consensus.

GSK2801 by ETNPPL expression — LARGE_INTESTINE

Box plot of GSK2801 in ETNPPL-low vs ETNPPL-high samples in LARGE_INTESTINE.

Explore this box plot interactively →

Exploration